According to Xinhuanet, medical researchers in Cuba have developed a vaccine for lung cancer.
The CimaVax-EGF vaccine, as a result of a 25-year research into diseases related to tobacco smoking, has been developed by researchers and scientists at the Center of Molecular Immunology (CIM) in Havana.
The active drug ingredient in the vaccine is based on “a protein we all have when cancer is uncontrolled.” “The epidermal growth factor is related to all cell proliferation,” said Gisela Gonzalez, head researcher of the project.
“The drug could turn the cancer into a manageable, chronic disease by generating antibodies against the proteins which triggered the uncontrolled cell proliferation,” she said.
The drug is not a preventative vaccine, such as the ones we are all given in childhood. It would be administered to patients with advanced stage cancer after conventional treatments have not been effective. It would then be used to attack the mechanism that causes the uncontrolled growth that is a defining characteristic of cancer.
She said the CimaVax-EGF has gone through clinical studies and trials in over 1,000 patients across the island and is currently distributed free of charge in all hospitals of the Caribbean island nation.
Gonzalez also said researchers at the CIM planned to use the same principle of the CimaVax-EGF in treating other cancerous tumors such as prostate, uterus and breast cancers.
Be seeing you.